CN116983357A - 治疗流感、病毒性肝炎的藏药组合物以及制备方法和应用 - Google Patents
治疗流感、病毒性肝炎的藏药组合物以及制备方法和应用 Download PDFInfo
- Publication number
- CN116983357A CN116983357A CN202311045674.9A CN202311045674A CN116983357A CN 116983357 A CN116983357 A CN 116983357A CN 202311045674 A CN202311045674 A CN 202311045674A CN 116983357 A CN116983357 A CN 116983357A
- Authority
- CN
- China
- Prior art keywords
- artificial
- viral hepatitis
- tibetan medicine
- portions
- treating influenza
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 71
- 206010019799 Hepatitis viral Diseases 0.000 title claims abstract description 35
- 206010022000 influenza Diseases 0.000 title claims abstract description 35
- 201000001862 viral hepatitis Diseases 0.000 title claims abstract description 35
- 239000000203 mixture Substances 0.000 title claims abstract description 22
- 238000002360 preparation method Methods 0.000 title claims abstract description 12
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims abstract description 37
- 206010004542 Bezoar Diseases 0.000 claims abstract description 33
- 239000006187 pill Substances 0.000 claims abstract description 33
- JHGWQSGWUPCKNT-UHFFFAOYSA-N 2-tert-butyl-4-methyl-1,3,5-trinitrobenzene Chemical compound CC1=C([N+]([O-])=O)C=C([N+]([O-])=O)C(C(C)(C)C)=C1[N+]([O-])=O JHGWQSGWUPCKNT-UHFFFAOYSA-N 0.000 claims abstract description 29
- 239000011593 sulfur Substances 0.000 claims abstract description 27
- 229910052717 sulfur Inorganic materials 0.000 claims abstract description 27
- 240000007311 Commiphora myrrha Species 0.000 claims abstract description 22
- 235000006965 Commiphora myrrha Nutrition 0.000 claims abstract description 22
- 235000007162 Ferula assa foetida Nutrition 0.000 claims abstract description 21
- 244000228957 Ferula foetida Species 0.000 claims abstract description 21
- 235000012850 Ferula foetida Nutrition 0.000 claims abstract description 21
- 235000007265 Myrrhis odorata Nutrition 0.000 claims abstract description 21
- 235000015489 Emblica officinalis Nutrition 0.000 claims abstract description 19
- 244000277583 Terminalia catappa Species 0.000 claims abstract description 19
- 235000011517 Terminalia chebula Nutrition 0.000 claims abstract description 19
- 241000227129 Aconitum Species 0.000 claims abstract description 13
- 244000205574 Acorus calamus Species 0.000 claims abstract description 13
- 235000011996 Calamus deerratus Nutrition 0.000 claims abstract description 13
- 239000000843 powder Substances 0.000 claims description 29
- 239000011812 mixed powder Substances 0.000 claims description 13
- 238000002156 mixing Methods 0.000 claims description 12
- 244000153234 Hibiscus abelmoschus Species 0.000 claims description 10
- 238000000227 grinding Methods 0.000 claims description 10
- 241001057584 Myrrha Species 0.000 claims description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 7
- 238000001035 drying Methods 0.000 claims description 6
- 238000000034 method Methods 0.000 claims 6
- 230000009286 beneficial effect Effects 0.000 abstract description 2
- 230000000694 effects Effects 0.000 description 12
- 201000010099 disease Diseases 0.000 description 9
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 9
- 229940079593 drug Drugs 0.000 description 8
- 208000002193 Pain Diseases 0.000 description 7
- 208000035473 Communicable disease Diseases 0.000 description 5
- 206010042674 Swelling Diseases 0.000 description 5
- 230000008961 swelling Effects 0.000 description 5
- 241000712461 unidentified influenza virus Species 0.000 description 4
- 206010010774 Constipation Diseases 0.000 description 3
- 206010010904 Convulsion Diseases 0.000 description 3
- 206010062717 Increased upper airway secretion Diseases 0.000 description 3
- 206010037660 Pyrexia Diseases 0.000 description 3
- 230000000740 bleeding effect Effects 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 230000036461 convulsion Effects 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 244000045947 parasite Species 0.000 description 3
- 208000026435 phlegm Diseases 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 206010063409 Acarodermatitis Diseases 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 206010068319 Oropharyngeal pain Diseases 0.000 description 2
- 206010034038 Parotitis Diseases 0.000 description 2
- 201000007100 Pharyngitis Diseases 0.000 description 2
- 241000447727 Scabies Species 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 230000000295 complement effect Effects 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 208000001848 dysentery Diseases 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 208000005687 scabies Diseases 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 238000010792 warming Methods 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 208000037157 Azotemia Diseases 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 206010007882 Cellulitis Diseases 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 206010053155 Epigastric discomfort Diseases 0.000 description 1
- 208000010228 Erectile Dysfunction Diseases 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- 206010069767 H1N1 influenza Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- 208000006083 Hypokinesia Diseases 0.000 description 1
- 208000002979 Influenza in Birds Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 206010026749 Mania Diseases 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 208000009620 Orthomyxoviridae Infections Diseases 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- 206010035148 Plague Diseases 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 206010060862 Prostate cancer Diseases 0.000 description 1
- 208000000236 Prostatic Neoplasms Diseases 0.000 description 1
- 208000036071 Rhinorrhea Diseases 0.000 description 1
- 206010039101 Rhinorrhoea Diseases 0.000 description 1
- 208000008765 Sciatica Diseases 0.000 description 1
- 208000002474 Tinea Diseases 0.000 description 1
- 241000130764 Tinea Species 0.000 description 1
- 206010044565 Tremor Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 208000003443 Unconsciousness Diseases 0.000 description 1
- 206010072589 Viral parotitis Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 241000607479 Yersinia pestis Species 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- 206010064097 avian influenza Diseases 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 229910052798 chalcogen Inorganic materials 0.000 description 1
- 150000001787 chalcogens Chemical class 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000007882 cirrhosis Effects 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 208000021760 high fever Diseases 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 201000007270 liver cancer Diseases 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 208000014018 liver neoplasm Diseases 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 230000001932 seasonal effect Effects 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- 206010041232 sneezing Diseases 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 208000002254 stillbirth Diseases 0.000 description 1
- 231100000537 stillbirth Toxicity 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 235000019605 sweet taste sensations Nutrition 0.000 description 1
- 201000010740 swine influenza Diseases 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 208000009852 uremia Diseases 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/37—Digestive system
- A61K35/413—Gall bladder; Bile
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/55—Glands not provided for in groups A61K35/22 - A61K35/545, e.g. thyroids, parathyroids or pineal glands
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/13—Coniferophyta (gymnosperms)
- A61K36/15—Pinaceae (Pine family), e.g. pine or cedar
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/328—Commiphora, e.g. mecca myrrh or balm of Gilead
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/714—Aconitum (monkshood)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Oncology (AREA)
- Biomedical Technology (AREA)
- Developmental Biology & Embryology (AREA)
- Zoology (AREA)
- Inorganic Chemistry (AREA)
- Immunology (AREA)
- Cell Biology (AREA)
- Pulmonology (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Endocrinology (AREA)
- Gastroenterology & Hepatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
本发明公开了一种治疗流感、病毒性肝炎的藏药组合物,包括诃子、穆库尔没药、京墨、硫黄、藏菖蒲、草乌、阿魏、人工牛黄、人工麝香;按照重量份数,包括有5~10份的诃子、2~8份的穆库尔没药、2~8份的京墨、2~8份的硫黄、2~8份的藏菖蒲、1~3份的草乌、2~6份的阿魏、0.2~0.8份的人工牛黄、0.1~0.3份的人工麝香。本发明还公开了使用上述治疗流感、病毒性肝炎的藏药组合物的制备方法和应用;本发明的有益效果是:本发明制备的重要丸剂在防治流感、病毒性肝炎上有显著功效,且能够内服使用。
Description
技术领域
本发明涉及藏药领域,特别是一种治疗流感、病毒性肝炎的藏药组合物以及制备方法和应用。
背景技术
传染病是经过各种途径传染给另一个人或物种的感染病。通常这种疾病可借由直接接触已感染的个体、感染者的体液及排泄物、感染者所污染到的物体,可以通过空气传播、水源传播、食物传播、接触传播、土壤传播、垂直传播(母婴传播)、体液传播、粪口传播等。具备传染性的疾病非常多,例如流感、病毒性肝炎、病毒性腮腺炎等等。
流行性感冒病毒简称流感病毒,其分为甲型、乙型和丙型,近年来还发现了丁型流感病毒。流感病毒可引起感染和发病,是人流感、猪流感和禽流感等疾病的病原。这些疾病典型的临床症状是发烧、全身疼痛、乏力,以及打喷嚏、流鼻涕、咽喉痛、呼吸急促等呼吸道症状。病毒性肝炎是由多种肝炎病毒引起的以肝脏病变为主的一种传染病。临床上以食欲减退、恶心、上腹部不适、肝区痛、乏力为主要表现。部分病人可有黄疸发热和肝大伴有肝功能损害。有些病人可慢性化,甚至发展成肝硬化,少数可发展为肝癌。
上述的几种传染性疾病,中医典籍中都有针对性的复方去防治,但是没有一种综合性的藏药复方,能够有效预防和治疗多种传染性疾病。由于传染性的疾病,大多具有流行性和季节性,对这些疾病的防治往往存在困难。
发明内容
本发明的目的在于克服现有技术的缺点,提供一种治疗流感、病毒性肝炎的藏药组合物以及制备方法和应用。
本发明的目的通过以下技术方案来实现:一种治疗流感、病毒性肝炎的藏药组合物,包括诃子、穆库尔没药、京墨、硫黄、藏菖蒲、草乌、阿魏、人工牛黄、人工麝香;
按照重量份数,包括有5~10份的诃子、2~8份的穆库尔没药、2~8份的京墨、2~8份的硫黄、2~8份的藏菖蒲、1~3份的草乌、2~6份的阿魏、0.2~0.8份的人工牛黄、0.1~0.3份的人工麝香;
本发明还提供一种治疗流感、病毒性肝炎的藏药制备方法,采用上述治疗流感、病毒性肝炎的藏药组合物制备;
进一步的,采用如下步骤制备:
1)将人工牛黄、人工麝香研磨成粉,备用;
2)将诃子、穆库尔没药、京墨、硫黄、藏菖蒲、草乌、阿魏混合研磨成粉,加入人工牛黄粉、人工麝香粉,混合均匀,得到混合粉末;
3)将步骤2)所得到的混合粉末以水泛丸,干燥,即得;
所述硫黄粉的粒度为80~100目,人工麝香粉的粒度为80~100目,所述诃子、穆库尔没药、京墨、牛黄人工、藏菖蒲、草乌、阿魏混合研磨成粉的粒度为100~200目;
进一步的,每丸重0.1g。
本发明还提供一种治疗流感、病毒性肝炎的藏药的应用,所述藏药组合物采用上述的制备方法制备得到;
进一步的,采用佩戴或口服的方式使用。
本发明具有以下优点:
1、本发明提供一种治疗流感、病毒性肝炎的藏药组合物,包括诃子、穆库尔没药、京墨、硫黄、藏菖蒲、草乌、阿魏、人工牛黄、人工麝香;诃子有敛肺涩肠、治疗慢性痢疾之效。穆库尔没药具有软坚消肿,强筋养肌,止咳化痰,润肠通便的功效,药理活性的研究表明穆库尔没药具有抗前列腺癌、降血脂、抗炎、抗心功能不全和保护心脏的作用等,可主治黏液质性或湿寒性疾病,如颈淋巴结核、痔疮肿胀、坐骨神经痛、瘫痪、肢颤症,大便不畅,咳嗽、痰多等。京墨,味辛,吐衄下血,产后崩中,止血甚捷。硫黄,为自然元素类矿物硫族自然硫,主要成分为硫磺,外用解毒杀虫疗疮;内服补火助阳通便;外治用于疥癣,秃疮,阴疽恶疮;内服用于阳痿足冷,虚喘冷哮,虚寒便秘。藏菖蒲具有温胃、消炎止痛之功效,可用于治疗一些病症,外用可敷疮疥,具有补体强身、驱虫、避瘟、防病的功效。草乌具有祛风除湿,温经止痛的功效,用于治寒湿瘀血留滞经络。阿魏具有消积,化瘕,散痞,杀虫的功效。人工牛黄气清香,味微苦而后甜,性平;可用于解热、解毒、定惊。内服治高热神志昏迷、癫狂、小儿惊风、抽搐等症,外用治咽喉肿痛、口疮痈肿、尿毒症。本发明中使用的是人工人工牛黄。人工麝香,具有开窍醒神,活血通经,消肿止痛的功效。主治闭证神昏,疮疡肿毒,瘰疬痰核,咽喉肿痛,血瘀经闭,症瘕,心腹暴痛,头痛,跌打损伤,风寒湿痹,难产,死胎,胞衣不下;本发明使用的人工麝香为人工人工麝香。
2、本发明的治疗流感、病毒性肝炎的藏药组合物,以诃子、穆库尔没药、京墨、硫黄、藏菖蒲、草乌、阿魏、人工牛黄、人工麝香组合使用,诃子、穆库尔没药为君药,京墨、藏菖蒲、草乌、阿魏为臣药,硫磺、人工牛黄、人工麝香为佐使药;几味药相辅相成,在防治流感、病毒性肝炎、痢疾、腮腺炎上有显著功效。
3、本发明的治疗流感、病毒性肝炎的藏药,通过合理的配伍方式以及制备方式,使其可以口服使用,而不只是常规的外用药,有效提高药效,同时有利于更广泛的应用。
具体实施方式
为使本发明实施方式的目的、技术方案和优点更加清楚,下面对本发明实施方式中的技术方案进行清楚、完整地描述,显然,所描述的实施方式是本发明一部分实施方式,而不是全部的实施方式。
因此,以下对本发明的实施方式的详细描述并非旨在限制要求保护的本发明的范围,而是仅仅表示本发明的选定实施方式。基于本发明中的实施方式,本领域普通技术人员在没有作出创造性劳动前提下所获得的所有其他实施方式,都属于本发明保护的范围。
需要说明的是,在不冲突的情况下,本发明中的实施方式及实施方式中的特征可以相互组合。
实施例1:一种治疗流感、病毒性肝炎的藏药组合物,包括诃子、穆库尔没药、京墨、硫黄、藏菖蒲、草乌、阿魏、人工牛黄、人工麝香;
按照重量份数,包括有5~10份的诃子、2~8份的穆库尔没药、2~8份的京墨、2~8份的硫黄、2~8份的藏菖蒲、1~3份的草乌、2~6份的阿魏、0.2~0.8份的人工牛黄、0.1~0.3份的人工麝香。
实施例2:一种治疗流感、病毒性肝炎的藏药组合物,按照重量份数,包括有5份的诃子、2份的穆库尔没药、2份的京墨、2份的硫黄、2份的藏菖蒲、1份的草乌、2份的阿魏、0.2份的人工牛黄、0.1份的人工麝香。
实施例3:一种治疗流感、病毒性肝炎的藏药组合物,按照重量份数,包括有10份的诃子、8份的穆库尔没药、8份的京墨、8份的硫黄、8份的藏菖蒲、3份的草乌、6份的阿魏、0.8份的人工牛黄、0.3份的人工麝香。
实施例4:一种治疗流感、病毒性肝炎的藏药组合物,按照重量份数,包括有8份的诃子、5份的穆库尔没药、5份的京墨、5份的硫黄、5份的藏菖蒲、2份的草乌、4份的阿魏、0.5份的人工牛黄、0.2份的人工麝香;
实施例5:一种藏药丸剂,采用如下治疗流感、病毒性肝炎的藏药组合物制成,按照重量份数,8份的诃子、5份的穆库尔没药、5份的京墨、5份的硫黄、5份的藏菖蒲、2份的草乌、4份的阿魏、0.5份的人工牛黄、0.2份的人工麝香;
上述藏药丸剂采用如下步骤制备:
1)将硫黄、人工麝香研磨成粉,备用;
2)将诃子、穆库尔没药、京墨、人工牛黄、藏菖蒲、草乌、阿魏混合研磨成粉,加入硫黄粉、人工麝香粉,混合均匀,得到混合粉末;
3)将步骤2)所得到的混合粉末以水泛丸,干燥,即得;
所述硫黄粉的粒度为80~100目,人工麝香粉的粒度为80~100目,所述诃子、穆库尔没药、京墨、人工牛黄、藏菖蒲、草乌、阿魏混合研磨成粉的粒度为100~200目;
所述藏药丸剂每丸重0.1g;
所述藏药丸剂采用佩戴或口服的方式使用;佩戴时,戴在胸前,每天鼻嗅2~3次;内服,一次1~2丸,一日2次,老幼及体弱者酌减或遵医嘱。
所述藏药丸剂用于防治流感效果显著。
实施例6:一种藏药丸剂,采用如下治疗流感、病毒性肝炎的藏药组合物制成,按照重量份数,8份的诃子、6份的穆库尔没药、6份的京墨、6份的硫黄、3份的藏菖蒲、3份的草乌、6份的阿魏、0.5份的人工牛黄、0.2份的人工麝香;
上述藏药丸剂采用如下步骤制备:
1)将硫黄、人工麝香研磨成粉,备用;
2)将诃子、穆库尔没药、京墨、人工牛黄、藏菖蒲、草乌、阿魏混合研磨成粉,加入硫黄粉、人工麝香粉,混合均匀,得到混合粉末;
3)将步骤2)所得到的混合粉末以水泛丸,干燥,即得;
所述硫黄粉的粒度为80~100目,人工麝香粉的粒度为80~100目,所述诃子、穆库尔没药、京墨、人工牛黄、藏菖蒲、草乌、阿魏混合研磨成粉的粒度为100~200目;
所述藏药丸剂每丸重0.1g;
所述藏药丸剂采用佩戴或口服的方式使用;佩戴时,戴在胸前,每天鼻嗅2~3次;内服,一次1~2丸,一日2次,老幼及体弱者酌减或遵医嘱。
所述藏药丸剂用于防治病毒性肝炎效果显著。
实施例7:一种藏药丸剂,采用如下治疗流感、病毒性肝炎的藏药组合物制成,按照重量份数,8份的诃子、6份的穆库尔没药、4份的京墨、4份的硫黄、3份的藏菖蒲、3份的草乌、4份的阿魏、0.5份的人工牛黄、0.2份的人工麝香;
上述藏药丸剂采用如下步骤制备:
1)将硫黄、人工麝香研磨成粉,备用;
2)将诃子、穆库尔没药、京墨、人工牛黄、藏菖蒲、草乌、阿魏混合研磨成粉,加入硫黄粉、人工麝香粉,混合均匀,得到混合粉末;
3)将步骤2)所得到的混合粉末以水泛丸,干燥,即得;
所述硫黄粉的粒度为80~100目,人工麝香粉的粒度为80~100目,所述诃子、穆库尔没药、京墨、人工牛黄、藏菖蒲、草乌、阿魏混合研磨成粉的粒度为100~200目;
所述藏药丸剂每丸重0.1g;
所述藏药丸剂采用佩戴或口服的方式使用;佩戴时,戴在胸前,每天鼻嗅2~3次;内服,一次1~2丸,一日2次,老幼及体弱者酌减或遵医嘱。
所述藏药丸剂用于防治痢疾效果显著。
实施例8:一种藏药丸剂,采用如下治疗流感、病毒性肝炎的藏药组合物制成,按照重量份数,8份的诃子、8份的穆库尔没药、2份的京墨、2份的硫黄、2份的藏菖蒲、2份的草乌、2份的阿魏、0.5份的人工牛黄、0.2份的人工麝香;
上述藏药丸剂采用如下步骤制备:
1)将硫黄、人工麝香研磨成粉,备用;
2)将诃子、穆库尔没药、京墨、人工牛黄、藏菖蒲、草乌、阿魏混合研磨成粉,加入硫黄粉、人工麝香粉,混合均匀,得到混合粉末;
3)将步骤2)所得到的混合粉末以水泛丸,干燥,即得;
所述硫黄粉的粒度为80~100目,人工麝香粉的粒度为80~100目,所述诃子、穆库尔没药、京墨、人工牛黄、藏菖蒲、草乌、阿魏混合研磨成粉的粒度为100~200目;
所述藏药丸剂每丸重0.1g;
所述藏药丸剂采用佩戴或口服的方式使用;佩戴时,戴在胸前,每天鼻嗅2~3次;内服,一次1~2丸,一日2次,老幼及体弱者酌减或遵医嘱。
所述藏药丸剂还可用于治疗腮腺炎。
尽管参照前述实施例对本发明进行了详细的说明,对于本领域的技术人员来说,其依然可以对前述各实施例所记载的技术方案进行修改,或者对其中部分技术特征进行等同替换,凡在本发明的精神和原则之内,所作的任何修改、等同替换、改进等,均应包含在本发明的保护范围之内。
Claims (8)
1.一种治疗流感、病毒性肝炎的藏药组合物,其特征在于:包括诃子、穆库尔没药、京墨、硫黄、藏菖蒲、草乌、阿魏、人工牛黄、人工麝香。
2.根据权利要求1所述的治疗流感、病毒性肝炎的藏药组合物,其特征在于:按照重量份数,包括有5~10份的诃子、2~8份的穆库尔没药、2~8份的京墨、2~8份的硫黄、2~8份的藏菖蒲、1~3份的草乌、2~6份的阿魏、0.2~0.8份的人工牛黄、0.1~0.3份的人工麝香。
3.一种治疗流感、病毒性肝炎的藏药制备方法,其特征在于:采用权利要求2所述治疗流感、病毒性肝炎的藏药组合物制备。
4.根据权利要求4所述的治疗流感、病毒性肝炎的藏药制备方法,其特征在于:采用如下步骤制备:
1)将人工牛黄、人工麝香研磨成粉,备用;
2)将诃子、穆库尔没药、京墨、硫黄、藏菖蒲、草乌、阿魏混合研磨成粉,加入人工牛黄粉、人工麝香粉,混合均匀,得到混合粉末;
3)将步骤2)所得到的混合粉末以水泛丸,干燥,即得。
5.根据权利要求4所述的治疗流感、病毒性肝炎的藏药制备方法,其特征在于:所述硫黄粉的粒度为80~100目,人工麝香粉的粒度为80~100目,所述诃子、穆库尔没药、京墨、人工牛黄、藏菖蒲、草乌、阿魏混合研磨成粉的粒度为100~200目。
6.根据权利要求4所述的治疗流感、病毒性肝炎的藏药制备方法,其特征在于:每丸重0.1g。
7.一种治疗流感、病毒性肝炎的藏药的应用,其特征在于:所述藏药采用权利要求3-6中任一项所述的制备方法制备得到。
8.根据权利要求7所述的治疗流感、病毒性肝炎的藏药的应用,其特征在于:采用佩戴或口服的方式使用。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202311045674.9A CN116983357A (zh) | 2023-08-18 | 2023-08-18 | 治疗流感、病毒性肝炎的藏药组合物以及制备方法和应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202311045674.9A CN116983357A (zh) | 2023-08-18 | 2023-08-18 | 治疗流感、病毒性肝炎的藏药组合物以及制备方法和应用 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN116983357A true CN116983357A (zh) | 2023-11-03 |
Family
ID=88524711
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202311045674.9A Pending CN116983357A (zh) | 2023-08-18 | 2023-08-18 | 治疗流感、病毒性肝炎的藏药组合物以及制备方法和应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN116983357A (zh) |
-
2023
- 2023-08-18 CN CN202311045674.9A patent/CN116983357A/zh active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102357146B (zh) | 一种治疗脚气的中药 | |
CN101028376A (zh) | 一种治疗习惯性流产的中药制剂 | |
CN105816842A (zh) | 一种杀菌、祛风通络止痛药酒及其制备方法 | |
CN103356865B (zh) | 一种治疗急性肾炎的中药制剂 | |
CN104587206A (zh) | 治疗褥疮的药物及制备方法 | |
CN101028490A (zh) | 一种治疗痤疮的中成药 | |
CN114028507A (zh) | 一种治疗腰痛的中药制备方法 | |
CN116983357A (zh) | 治疗流感、病毒性肝炎的藏药组合物以及制备方法和应用 | |
CN1857450A (zh) | 一种治疗痛经的中药制剂 | |
CN100450537C (zh) | 一种治疗前列腺增生的中药制剂 | |
CN105311520A (zh) | 一种治疗跌打损伤中药搽剂 | |
CN101028491A (zh) | 一种治疗带状疱疹的中药制剂 | |
CN1231254C (zh) | 治疗结核病的药物及其制备方法 | |
CN101028352A (zh) | 一种治疗坐骨神经痛的中药制剂 | |
CN102366484A (zh) | 一种治疗带状疱疹的药物组合物及制备方法 | |
CN102000177B (zh) | 一种治疗痔疮的药物 | |
CN116115681A (zh) | 一种用于制备治疗扁桃体发炎药物的配方及方法 | |
CN1256976C (zh) | 一种抗癌中药组合物及其制备方法 | |
CN104815293A (zh) | 一种治疗中耳炎的中药片剂及其制备方法 | |
CN104189866A (zh) | 一种治疗膝关节骨质增生的外用中药酒 | |
CN114177268A (zh) | 一种加味万应筋骨贴及其制备方法 | |
CN118021880A (zh) | 一种中药组合物及其制备方法和应用 | |
CN102847108B (zh) | 男性壮阳脐贴膏及其制备方法 | |
CN104116991A (zh) | 一种治疗放射病的中药制剂及制备方法 | |
CN114832074A (zh) | 一种预防或治疗非洲猪瘟的中药组合物及其制备方法和用途 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |